لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

المؤلفون: Lori Jukofsky, Mark Drummond, Karen W.L. Yee, Gong Chen, Vivian Ruvolo, Roger Strair, Mark Kirschbaum, Peter Bridge, Kensuke Kojima, Steven Blotner, Jianguo Zhi, Leslie Popplewell, Gwen Nichols, Bradford Graves, Michael Andreeff, Kevin R. Kelly, Ruediger Rueger, Steve Middleton, Monica Reckner, Xuelin Huang, Graciela M. Nogueras González, Giovanni Martinelli, Swaminathan Padmanabhan Iyer, Paresh Vyas, Sarit Assouline, David G. Bowen

المساهمون: Andreeff, M, Kelly, Kr, Yee, Kw, Assouline, Se, Strair, R, Popplewell, L, Bowen, D, Martinelli, Giovanni, Drummond, Mw, Vyas, P, Kirschbaum, Mh, Padmanabhan Iyer, S, Ruvolo, Vr, Nogueras Gonzalez, Gm, Huang, X, Chen, Guodong, Graves, B, Blotner, S, Bridge, P, Jukofsky, L, Middleton, S, Reckner, M, Rueger, R, Zhi, J, Nichols, G, Kojima, K.

مصطلحات موضوعية: 0301 basic medicine, Acute promyelocytic leukemia, Oncology, Cancer Research, medicine.medical_specialty, Pharmacology, 03 medical and health sciences, 0302 clinical medicine, MDM2, Internal medicine, hemic and lymphatic diseases, medicine, Adverse effect, neoplasms, business.industry, Myeloid leukemia, Cancer, medicine.disease, Leukemia, 030104 developmental biology, 030220 oncology & carcinogenesis, Pharmacodynamics, Refractory Chronic Lymphocytic Leukemia, business, Chronic myelogenous leukemia

وصف الملف: ELETTRONICO

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::689607b3ccb62655a1526be46e71f3fe
http://hdl.handle.net/11585/592949

المؤلفون: van Dijk AD; Division of Pediatric Oncology and Hematology, Department of Pediatrics, University Medical Center Groningen, University of Groningen, 9713 GZ Groningen, The Netherlands.; Department of Leukemia, M.D. Anderson Cancer Center, The University of Texas, Houston, TX 78712, USA., Hoff FW; Division of Pediatric Oncology and Hematology, Department of Pediatrics, University Medical Center Groningen, University of Groningen, 9713 GZ Groningen, The Netherlands.; Department of Leukemia, M.D. Anderson Cancer Center, The University of Texas, Houston, TX 78712, USA., Qiu Y; Department of Leukemia, M.D. Anderson Cancer Center, The University of Texas, Houston, TX 78712, USA., Hubner SE; Department of Leukemia, M.D. Anderson Cancer Center, The University of Texas, Houston, TX 78712, USA., Go RL; Department of Leukemia, M.D. Anderson Cancer Center, The University of Texas, Houston, TX 78712, USA., Ruvolo VR; Department of Molecular Therapy and Hematology, M.D. Anderson Cancer Center, The University of Texas, Houston, TX 78712, USA., Leonti AR; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA., Gerbing RB; COG Statistics and Data Center, Monrovia, CA 91016, USA., Gamis AS; Department of Hematology-Oncology, Children's Mercy Hospitals and Clinics, Kansas City, MO 64108, USA., Aplenc R; Division of Pediatric Oncology and Stem Cell Transplant, Children's Hospital of Philadelphia, Philadelphia, PA 19104, USA., Kolb EA; Nemours Center for Cancer and Blood Disorders, Alfred I. DuPont Hospital for Children, Wilmington, DE 19803, USA., Alonzo TA; COG Statistics and Data Center, Monrovia, CA 91016, USA.; Keck School of Medicine, University of Southern California, Los Angeles, CA 90007, USA., Meshinchi S; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA., de Bont ESJM; Division of Pediatric Oncology and Hematology, Department of Pediatrics, University Medical Center Groningen, University of Groningen, 9713 GZ Groningen, The Netherlands., Horton TM; Texas Children's Cancer and Hematology Centers, Baylor College of Medicine, Houston, TX 77030, USA., Kornblau SM; Department of Leukemia, M.D. Anderson Cancer Center, The University of Texas, Houston, TX 78712, USA.

المصدر: Cancers [Cancers (Basel)] 2024 Apr 09; Vol. 16 (8). Date of Electronic Publication: 2024 Apr 09.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: MDPI Country of Publication: Switzerland NLM ID: 101526829 Publication Model: Electronic Cited Medium: Print ISSN: 2072-6694 (Print) Linking ISSN: 20726694 NLM ISO Abbreviation: Cancers (Basel) Subsets: PubMed not MEDLINE

المؤلفون: Akiyama H; Section of Molecular Hematology and Therapy, Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Zhao R; Section of Molecular Hematology and Therapy, Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Ostermann LB; Section of Molecular Hematology and Therapy, Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Li Z; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Tcheng M; Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada., Yazdani SJ; Section of Molecular Hematology and Therapy, Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Moayed A; Section of Molecular Hematology and Therapy, Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Pryor ML 2nd; Section of Molecular Hematology and Therapy, Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Slngh S; Section of Molecular Hematology and Therapy, Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Baran N; Section of Molecular Hematology and Therapy, Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Ayoub E; Section of Molecular Hematology and Therapy, Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Nishida Y; Section of Molecular Hematology and Therapy, Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Mak PY; Section of Molecular Hematology and Therapy, Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Ruvolo VR; Section of Molecular Hematology and Therapy, Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Carter BZ; Section of Molecular Hematology and Therapy, Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Schimmer AD; Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada., Andreeff M; Section of Molecular Hematology and Therapy, Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Ishizawa J; Section of Molecular Hematology and Therapy, Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. JIshizawa@mdanderson.org.

المصدر: Leukemia [Leukemia] 2024 Apr; Vol. 38 (4), pp. 926.

نوع المنشور: Published Erratum

بيانات الدورية: Publisher: Nature Publishing Group, Specialist Journals Country of Publication: England NLM ID: 8704895 Publication Model: Print Cited Medium: Internet ISSN: 1476-5551 (Electronic) Linking ISSN: 08876924 NLM ISO Abbreviation: Leukemia Subsets: PubMed not MEDLINE; MEDLINE

المؤلفون: Akiyama H; Section of Molecular Hematology and Therapy, Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Zhao R; Section of Molecular Hematology and Therapy, Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Ostermann LB; Section of Molecular Hematology and Therapy, Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Li Z; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Tcheng M; Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada., Yazdani SJ; Section of Molecular Hematology and Therapy, Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Moayed A; Section of Molecular Hematology and Therapy, Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Pryor ML 2nd; Section of Molecular Hematology and Therapy, Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Slngh S; Section of Molecular Hematology and Therapy, Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Baran N; Section of Molecular Hematology and Therapy, Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Ayoub E; Section of Molecular Hematology and Therapy, Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Nishida Y; Section of Molecular Hematology and Therapy, Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Mak PY; Section of Molecular Hematology and Therapy, Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Ruvolo VR; Section of Molecular Hematology and Therapy, Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Carter BZ; Section of Molecular Hematology and Therapy, Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Schimmer AD; Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada., Andreeff M; Section of Molecular Hematology and Therapy, Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Ishizawa J; Section of Molecular Hematology and Therapy, Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. JIshizawa@mdanderson.org.

المصدر: Leukemia [Leukemia] 2024 Apr; Vol. 38 (4), pp. 729-740. Date of Electronic Publication: 2023 Dec 26.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Nature Publishing Group, Specialist Journals Country of Publication: England NLM ID: 8704895 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5551 (Electronic) Linking ISSN: 08876924 NLM ISO Abbreviation: Leukemia Subsets: MEDLINE

مواضيع طبية MeSH: Ferroptosis* , Leukemia, Myeloid, Acute*/drug therapy , Leukemia, Myeloid, Acute*/metabolism, Humans ; Mitochondria/metabolism ; Lipids ; Peptide Hydrolases/metabolism

المؤلفون: Nishida Y; Section of Molecular Hematology and Therapy, Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Ishizawa J; Section of Molecular Hematology and Therapy, Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Ayoub E; Section of Molecular Hematology and Therapy, Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Montoya RH; Section of Molecular Hematology and Therapy, Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Ostermann LB; Section of Molecular Hematology and Therapy, Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Muftuoglu M; Section of Molecular Hematology and Therapy, Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Ruvolo VR; Section of Molecular Hematology and Therapy, Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Patsilevas T; Section of Molecular Hematology and Therapy, Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Scruggs DA; Section of Molecular Hematology and Therapy, Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Khazaei S; Section of Molecular Hematology and Therapy, Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Mak PY; Section of Molecular Hematology and Therapy, Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Tao W; Section of Molecular Hematology and Therapy, Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Carter BZ; Section of Molecular Hematology and Therapy, Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Boettcher S; Department of Medical Oncology and Haematology, University Hospital Zurich, University of Zurich, Zurich 8091, Switzerland.; Brigham and Women's Hospital, Dana-Farber Cancer Institute, Harvard Medical School, The Broad Institute, Boston, MA 02115, USA., Ebert BL; Brigham and Women's Hospital, Dana-Farber Cancer Institute, Harvard Medical School, The Broad Institute, Boston, MA 02115, USA., Daver NG; Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Konopleva M; Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.; Section of Leukemia Biology Research, Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Seki T; Daiichi Sankyo Co. Ltd., Tokyo 103-8426, Japan., Kojima K; Section of Molecular Hematology and Therapy, Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.; Department of Hematology, Kochi University, Nankoku, Kochi 783-8505, Japan., Andreeff M; Section of Molecular Hematology and Therapy, Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.

المصدر: Science advances [Sci Adv] 2023 Dec; Vol. 9 (48), pp. eadh1436. Date of Electronic Publication: 2023 Nov 29.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: American Association for the Advancement of Science Country of Publication: United States NLM ID: 101653440 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2375-2548 (Electronic) Linking ISSN: 23752548 NLM ISO Abbreviation: Sci Adv Subsets: MEDLINE

مواضيع طبية MeSH: Tumor Suppressor Protein p53*/genetics , Leukemia, Myeloid, Acute*/drug therapy , Leukemia, Myeloid, Acute*/genetics , Leukemia, Myeloid, Acute*/pathology, Humans ; Proto-Oncogene Proteins c-mdm2/genetics ; Proto-Oncogene Proteins c-mdm2/metabolism ; Cell Line, Tumor ; Apoptosis/genetics

المؤلفون: Bhattacharya S; Section of Molecular Hematology and Therapy, Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas., Piya S; Section of Molecular Hematology and Therapy, Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas., Ma H; Section of Molecular Hematology and Therapy, Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas., Sharma P; Section of Molecular Hematology and Therapy, Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas., Zhang Q; Section of Molecular Hematology and Therapy, Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas., Baran N; Section of Molecular Hematology and Therapy, Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas., Ruvolo VR; Section of Molecular Hematology and Therapy, Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas., McQueen T; Section of Molecular Hematology and Therapy, Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas., Davis RE; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, Texas., Pourebrahim R; Section of Molecular Hematology and Therapy, Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas., Konopleva M; Albert Einstein College of Medicine, Jack and Pearl Resnick Campus, Bronx, New York., Kantarjian H; Section of Molecular Hematology and Therapy, Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas., Cosford NDP; Sanford Burnham Prebys Medical Discovery Institute, La Jolla, California., Andreeff M; Section of Molecular Hematology and Therapy, Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas., Borthakur G; Section of Molecular Hematology and Therapy, Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas.

المصدر: Molecular cancer research : MCR [Mol Cancer Res] 2023 Jun 01; Vol. 21 (6), pp. 548-563.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural

بيانات الدورية: Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 101150042 Publication Model: Print Cited Medium: Internet ISSN: 1557-3125 (Electronic) Linking ISSN: 15417786 NLM ISO Abbreviation: Mol Cancer Res Subsets: MEDLINE

مواضيع طبية MeSH: Leukemia, Myeloid, Acute*/drug therapy , Leukemia, Myeloid, Acute*/genetics , Antineoplastic Agents*/pharmacology, Animals ; Mice ; Autophagy ; Drug Resistance, Neoplasm ; Apoptosis